State Board of Administration of Florida Retirement System raised its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 16.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 88,252 shares of the medical instruments supplier’s stock after buying an additional 12,609 shares during the period. State Board of Administration of Florida Retirement System owned approximately 0.12% of West Pharmaceutical Services worth $8,342,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in WST. Cambridge Investment Research Advisors Inc. boosted its position in West Pharmaceutical Services by 1.6% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 2,569 shares of the medical instruments supplier’s stock valued at $210,000 after buying an additional 40 shares during the period. Teacher Retirement System of Texas boosted its position in West Pharmaceutical Services by 0.7% in the second quarter. Teacher Retirement System of Texas now owns 5,867 shares of the medical instruments supplier’s stock valued at $555,000 after buying an additional 40 shares during the period. Private Advisor Group LLC boosted its position in West Pharmaceutical Services by 3.2% in the first quarter. Private Advisor Group LLC now owns 2,899 shares of the medical instruments supplier’s stock valued at $232,000 after buying an additional 91 shares during the period. PNC Financial Services Group Inc. boosted its position in West Pharmaceutical Services by 2.6% in the first quarter. PNC Financial Services Group Inc. now owns 6,806 shares of the medical instruments supplier’s stock valued at $556,000 after buying an additional 175 shares during the period. Finally, World Asset Management Inc boosted its position in West Pharmaceutical Services by 4.1% in the second quarter. World Asset Management Inc now owns 5,364 shares of the medical instruments supplier’s stock valued at $507,000 after buying an additional 211 shares during the period. 91.32% of the stock is owned by institutional investors and hedge funds.

Shares of West Pharmaceutical Services, Inc. (NYSE WST) opened at 87.49 on Friday. The firm has a market capitalization of $6.47 billion, a price-to-earnings ratio of 37.55 and a beta of 1.13. The stock has a 50 day moving average of $88.22 and a 200-day moving average of $88.86. West Pharmaceutical Services, Inc. has a 52 week low of $70.17 and a 52 week high of $99.91.

West Pharmaceutical Services (NYSE:WST) last announced its earnings results on Thursday, July 27th. The medical instruments supplier reported $0.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.65 by $0.01. The business had revenue of $397.60 million during the quarter, compared to analysts’ expectations of $406 million. West Pharmaceutical Services had a net margin of 11.42% and a return on equity of 14.02%. The firm’s revenue for the quarter was up 2.5% on a year-over-year basis. During the same quarter last year, the company posted $0.59 EPS. Analysts expect that West Pharmaceutical Services, Inc. will post $2.68 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 1st. Shareholders of record on Wednesday, October 18th will be given a $0.14 dividend. This represents a $0.56 annualized dividend and a yield of 0.64%. The ex-dividend date is Tuesday, October 17th. This is a boost from West Pharmaceutical Services’s previous quarterly dividend of $0.13. West Pharmaceutical Services’s dividend payout ratio (DPR) is presently 22.22%.

ILLEGAL ACTIVITY NOTICE: This report was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this report on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The original version of this report can be read at https://www.thecerbatgem.com/2017/09/02/state-board-of-administration-of-florida-retirement-system-acquires-12609-shares-of-west-pharmaceutical-services-inc-wst.html.

Several research analysts have commented on the stock. BidaskClub cut shares of West Pharmaceutical Services from a “sell” rating to a “strong sell” rating in a research report on Thursday, August 3rd. Zacks Investment Research cut shares of West Pharmaceutical Services from a “hold” rating to a “sell” rating in a research report on Wednesday, July 19th. Finally, Jefferies Group LLC restated a “hold” rating and issued a $90.00 target price on shares of West Pharmaceutical Services in a research report on Thursday, June 8th. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and two have issued a buy rating to the company. West Pharmaceutical Services currently has an average rating of “Hold” and a consensus price target of $90.18.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Stock Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related stocks with our FREE daily email newsletter.